Pinned Tweet
I’m sharing my first investment article on the Finnish forum Sijoitustieto - covering $LMND.
Happy to hear your views and feedback - more articles to come in the future.
Summary:
I see $LMND as a high-risk, high-beta investment case, with its story centered on the company’s ability to disrupt the traditional insurance market over the coming years. The numbers show early signs that the fundamentals are moving in the right direction. During H2, I’ll be closely watching the development of IFP (in-force premium). As the business scales through growth investments, I believe the company can reach positive EBITDA next year.
sijoitustieto.fi/sijoitusart…
Sijoitustietoon saatiin uusi erinomainen kirjoittaja @ValueByMarkus . Ensimmäisessä artikkelissaan hän analysoi vakuutusalan disruptoijaa, Lemonadea.
”…ensimmäinen puhtaasti diginatiivi vakuutusyhtiö, joka lupasi mullistaa alan mm. tekoälyn avulla.”
sijoitustieto.fi/sijoitusart…
$LMND Investor Day 2026.
Great presentations, and demos but perhaps even more valuable were the discussions with the executive team and fellow investors.
Lots of insights and takeaways to digest.
1
42
2,280
The $META Lab on 5th Avenue was absolutely amazing.
Got to try the new Meta x Ray-Ban AI glasses. Surprisingly comfortable, and the AI listening / audio capabilities and recording features were far more advanced than I expected.
7
1,092
Cool to see and try the Apple Duo at the NYC flagship store.
While I don't see the value in the + $2k price tag, it felt great in person and I can understand the hype around it.
Always great to see $AAPL continuing to innovate
1
14
1,478
Travel reading on the way to New York.
Can’t wait for the $LMND Investor Day on Tuesday
4
69
3,905
📚 Kicking off my book thread! 📚 Join me as I share the books that shaped my mind and took me on unforgettable journeys. Let's dive into the pages together! #BookThread
42/x
The Compounders by @oddbjorndybvad @kjetil_nyland @adnaninvest
9.5/10
A great book on a very interesting topic for me: what makes the successful serial acquirer model work and how it can drive exceptional shareholder returns.
Great examples, mainly from Sweden, including legendary names like Lifco and Addtech, but also global names such as Constellation Software.
The book emphasizes the well-known themes behind the model: decentralization, return on capital, organic growth, leverage, and the importance of culture, but the real-life examples really bring these concepts to life.
An absolute must-read for investors who either own serial acquirers or have an interest in the model, which can generate exceptional long-term returns when executed well.
43/x
The Infinity Machine by @scmallaby
9/10
A fascinating look into the mind of Demis Hassabis and the journey behind DeepMind.
Part biography, part history of AI, and part exploration of the race towards AGI.
A few takeaways:
DeepMind was founded with an extremely ambitious long-term mission: solve intelligence and use it to accelerate scientific discovery. AlphaGo and AlphaFold were milestones along the way, not the original end goal.
DeepMind spent years pursuing different approaches to intelligence. Some worked, others didn’t. The combination of deep learning, reinforcement learning and massive computational resources ultimately proved powerful.
The tension between scientific ambition, commercial incentives, competition and AI safety. Once a transformational technology exists, controlling its development and deployment becomes extremely difficult.
3
440
Added to my $LMND position today. Here’s why I like the current risk/reward:
1) Growth is materializing as expected.
IFP is accelerating at +30% YoY, with strong performance across product categories, particularly Pet + Car.
2) Cross-selling and geographical expansion are working.
Cross-selling continues to gain traction, while geographical expansion (e.g. Renters now available in all states) has progressed well YTD. This is reflected in both customer growth and IFP per customer.
3) Autonomous driving is an interesting long-term option.
Lemonade Car is gradually expanding. While still immaterial to overall numbers, being early in a potentially significant scaling opportunity is an interesting bet on future growth.
4) Opex is the biggest question mark.
Rising operating expenses are imo the main reason behind the ~40% share price decline.
So far, I’m willing to buy management’s narrative around the cost structure, although I remain critical of the high SBC.
This is probably the most critical component of the investment thesis. I believe the heavy growth investment is justified given the current returns and customer LTV, but execution on operating leverage will ultimately determine the outcome.
5) Loss ratios are moving in the right direction, but there are pockets to monitor.
The overall trend is encouraging, but Q3 European and Pet gross loss ratios (104% and 75%,) deserve close attention.
6) Several upcoming catalysts.
Investor Day is coming up next week, and I’m looking forward to participating and meeting management and other investors.
I’m particularly interested in how management communicates its agentic AI capabilities and the potential impact on the business model.
Additionally, management has guided for positive adjusted EBITDA in Q4, with net profitability expected to follow later. Delivering on this would provide concrete evidence that the business model can generate profits while still investing heavily in growth.
7) Valuation and risk/reward.
This remains a high-beta, volatile business, and traditional insurance valuation multiples aren’t particularly useful here.
However, current LTM multiples are approx:
P/Sales: 2.8x
P/Gross Profit: 7x
Imo, these aren’t particularly demanding multiples for a business with this growth profile and potential, assuming management can keep operating expenses under control and scale profitability as communicated.
The bottom line: I’m willing to accept the volatility and execution risk given the potential upside. But the thesis ultimately depends on translating strong growth into sustainable operating leverage.
Happy to hear arguments against the thesis or any bear cases I’m potentially overlooking.
1
37
3,244
$IREN Q1 FY27 is out.
Key takeaways:
- AI Cloud quarterly revenue increased 182% QoQ to $200M. Operating ARR doubled to $1B.
- More than $4B of contracted ARR is now targeted for January, following "a customer-requested design change and supplier timing delays". The timeline could extend into February.
$15B of remaining planned FY27 CapEx, expected to be funded through:
- $9B from cash, committed GPU financing and prepayments.
- $6B from targeted GPU financing, prepayments, data center financing and other "corporate-level sources"
Some impressive growth numbers, but also plenty to unpack.
The $4B+ contracted ARR ramp is particularly important. The delay is worth understanding, especially given the execution requirements behind such an ambitious scaling.
I'm also interested in hearing management's comments. Hopefully, analysts will ask some tough hard ball questions, particularly around delivery timelines, financing certainty and the role of marketing partnerships.
"All currently permitted datacenters in Texas will be allowed to finish construction."
That sounds like a reasonable (political) approach for the AI infrastructure industry. Assuming this holds, I think visibility and predictability are exactly what the market and companies operating in AI cloud biz need at the moment.
For players like $IREN, I'd view this as positive. There are obviously still plenty of unanswered questions, starting from the management compensation, and marketing deals, but Texas remains a critical state, with $IREN having 4+ GW of capacity in its pipeline.
My assumption is that overall token demand will continue to grow despite tighter regulation and potential CapEx pushback. Ultimately, the players that can deliver infrastructure on time and execute well should be in a strong position to capture that demand and potentially benefit from pricing power.
Looking forward to $IREN's quarterly results in a few hours.
"All currently permitted datacenters in Texas will be allowed to finish construction."
That sounds like a reasonable (political) approach for the AI infrastructure industry. Assuming this holds, I think visibility and predictability are exactly what the market and companies operating in AI cloud biz need at the moment.
For players like $IREN, I'd view this as positive. There are obviously still plenty of unanswered questions, starting from the management compensation, and marketing deals, but Texas remains a critical state, with $IREN having 4+ GW of capacity in its pipeline.
My assumption is that overall token demand will continue to grow despite tighter regulation and potential CapEx pushback. Ultimately, the players that can deliver infrastructure on time and execute well should be in a strong position to capture that demand and potentially benefit from pricing power.
Looking forward to $IREN's quarterly results in a few hours.
The governor-elect of Texas, Gina Hinojosa, has explicitly said that all currently permitted datacenters in Texas will be allowed to finish construction. This essentially covers all of the 2027 and likely well into 2028.
She is going to pass laws that ensure that all *newly* permitted datacenters going forward for delivery in 2028/2029 will pay taxes, commit to no increase in power prices for consumers, don’t impact water availability for people, be constructed with union labor and give “Texans a seat at the table.”
Sounds reasonable. She doesn’t want to lose a lot of good blue collar jobs and property taxes for small towns in rural Texas.
Datacenter commentary starts at 6:30 in this interview.
Also attaching her official campaign position from her website in the next post.
Sidenote: After watching a bunch of her speeches and interviews, I do think she is a political talent and probably has a future in national politics.
youtu.be/D-T6H3b8ZeE?is=mEWu…
Wild times in the markets.
While I have some exposure to direct AI plays (Infra & applications), days like these are a good reminder of the importance of proper risk management and position sizing across sectors.
That said, I'm not overly concerned about AI infrastructure. This feels more like a capitulation/liquidation event driven by technical factors than a fundamental deterioration.
Surely, a midterm election win for the Democrats have implications for AI infrastructure Capex investments and local regulation, but I don't think this came as a surprise to the market. Much of it was likely already priced in.
Probably not a bad time to start looking at quality businesses trading at more attractive levels. Unfortunately, I don't have any extra cash to deploy at the moment.
Which companies are becoming increasingly attractive at current valuations?
6
1,065
$LMND Q3 Growth keeps accelerating
IFP $1.55B (+34%)
Revenue $336M (+73%)
Gross profit $118M (+48%)
Customers 3.52M (+23%)
Premium/customer $440 (+9%)
ADR 86% (+1pp YoY)
A few things stand out:
12 consecutive quarters of accelerating IFP growth.
Operating leverage: 2.5x+ IFP compared to four years ago, with fewer employees today (more on opex later)
Autonomous driving: Lemonade Car is now available in 14 states, covering >50% of the US population. Tesla FSD insurance conversion rates are reportedly >2x those of the broader Car product.
Profitability is getting closer. Management reiterated its target of positive Adj. EBITDA in Q4 2026 and expects the first full year of positive Adj. EBITDA in 2027.
That said, there are a couple of negatives I will deep dive into later:
Gross loss ratio increased to 65% (62%), especially concerning is the significant deterioration in Europe, where GLR reached 104% (vs. 70% YoY and 71% QoQ). What has happened in Europe?
Opex came in at $191M (+36% YoY). This caused considerable uncertainty following Q2. The entire investment case depends on how scalable the expansion really is, although growth spending has been delivering solid returns so far?
Overall, the combination of accelerating growth, improving unit economics and a scalable technology remains compelling. I’m very satisfied with Q3 at first glance.
Looking forward to participating in the November 17 Investor Day to hear more about the strategy and AI capabilities, and to meet fellow investors and management.
32
2,473
$TEQ biggest acquisition to date looks like a solid fit for its decentralized strategy.
Odlings Group is a UK-based niche group with 4 businesses spanning memorial products, manufacturing and specialist services.
- £10m+ annual revenue
- ~110 employees
- Established management teams staying on
- Loyal customers and "robust margins"
At £10m+ in annual sales, this will add meaningful ~6% non-organic growth on an LTM basis, likely imo at higher profitability than the current ~15% group EBIT margin.
Another niche business to own for the long term. Exactly the kind of deal I’ll be looking from $TEQ
Another boring, smaller, high-quality acquisition from $TEQ
Unique Door Panels: ~£3.8m average revenue ~SEK47m "robust margins", 100+ repeat customers and 20+ employees. Founder/MD stays on.
This acquisition adds ~3% of non-organic growth versus 2025 sales.
$TEQ has deployed capital fairly aggressively, but given the quality of recent acquisitions and the lessons learned from the legacy portfolio, I’m very satisfied to see news like this.
The market might not price in the combination of strong non-organic growth and improving profitability across the existing portfolio into 2027 and beyond.
What an exciting Q3 reporting day it has been. A 3/4 success rate across my portfolio.
$INCAP delivered strong sales growth of +50%, driven by both organic and inorganic growth. Profitability is also improving nicely.
$QTCOM, considering the previously weak sentiment, delivered a very solid +27% growth, while EBITA is also improving following the IAR M&A deal.
$BOREO grew sales by +26%, mainly organically, with EBIT improving significantly. Operating leverage is really kicking in, laying the foundation for M&A as the balance sheet gets much healthier following the refinancing.
$HARVIA delivered solid sales growth of +17%, but clearly fell short of what both the market and I were pricing in. EBIT margin was also soft at ~17%. Need to deep dive into this one.
Imo, this is a great time to pick businesses from the Nordic small-cap universe. Some of the risk/reward setups are becoming increasingly attractive.
1
22
2,323
$GOOGL Q3: Missed EPS, but the acceleration across legacy Search and AI is wild.
Sales: 127 B$ (+25%)
Operating margin: 31.8% (vs. 30.5%)
Capex: 51 B$ (+114%)
Absolutely wild numbers once again.
Search grew +12% YoY, showing no obvious signs of AI-driven disruption. Google Cloud is a monster business, with sales up ~100% YoY and a 36% operating margin, already generating 10 B$+ in quarterly operating income.
Meanwhile, token usage is growing +40% QoQ, even as questions remain around Gemini’s competitive positioning at the frontier and the economics of AI.
That said, shares are down almost 10% after hours following an EPS miss of up to 30% versus analyst consensus.
There’s been a lot of discussion around a potential $ANT IPO and its S-1 prospectus, and for good reason.
Below is by far the best summary I’ve read so far after skimming through the S-1.
I won’t participate in the IPO at a speculated $1.5–2T valuation, but it will be fascinating to follow Anthropic’s progress as a public company.
Frontier models are evolving weekly, increasing regulatory, safety concerns, open-source models are gaining market share even as the total market grows exponentially, and hundreds of billions in capex will be needed.
I’m happy to stay on the sidelines for now, even though I can see the bull case at a multi-trillion-dollar valuation.
Highly recommended read:
“With my upbeat story for Anthropic, I estimate a value for the equity of $1.475 trillion. If you are bullish, you will undoubtedly find ways to tweak my numbers to get you to whatever number you want.”
Anthropic's IPO was filed on October 26, 2026, and I value it's equity at about $1.475 trillion, which will inform my decision on whether to buy or sell its shares. To make your Anthropic choice, though, you should value it yourself, and I will provide a story and input structure to help you. bit.ly/3UTo3Gj
1
4
1,029
$IREN
I struggle to justify spending $20–50M per year on a Real Madrid partnership in the AI neocloud business.
When your business requires billions in capex, external financing and constant reinvestment in GPUs, capital allocation is critical.
Is the brand exposure really worth it?
15
54
5,961
$BSP up nearly 50% as Berkshire Hathaway doubles down on Bending Spoons, adding another $330M on top of its original $600M IPO investment.
Headquartered in Milan, Bending Spoons acquires established digital businesses, restructures operations, improves monetization and cash flow, then redeploys capital into further acquisitions.
Q2 2026:
Revenue: $704M, +126% YoY; organic growth + 3%
Adjusted operating income: $381M, a 54% margin
Leverage: 2.4x
The playbook is clear: buy mature digital assets, optimize costs and monetize existing users rather than rely on organic growth.
An Italian $CSU in the making?
1
11
1,061
$LVMH Q3: The weakness is concentrated in its most important profit engine.
Solid growth in the US, Europe and Japan, but weaker Chinese demand remains a headwind.
Q3 organic sales growth by segment:
- Fashion & Leather Goods: -5%
- Wines & Spirits: +6%
- Perfumes & Cosmetics: +1%
- Watches & Jewelry: +6%
- Selective Retailing: +8%
Imo, the key issue is China “Chinese clientele down mid-teens” (Asia ex-Japan -5% YoY), which is weighing on Fashion & Leather Goods, $LVMH crown jewel and a major profit contributor.
Loro Piana and the ultra-luxury segment have shown resilience, while demand for more accessible luxury, including Louis Vuitton, remains under pressure.
Interesting note from the earnings call:
“Management rejected price cuts at Louis Vuitton. It prefers to keep brand desirability and use self-help measures such as product newness. “
After a brutal ~40% YTD decline, the valuation at ~12 EV/EBIT multiple is starting to look very attractive.
$HGRAF So far, the timing has been spot on: ~70% downside since my original post, despite receiving some criticism for my initial views.
I still stand by my original thinking on this narrative-driven equity story. I see the potential for commercial scaling, and tech disruption but I still don’t see the hard evidence to justify even the current 1B$+ valuation.
I’ll keep following the story. I wish the business well, but based on the information available today, I’ll remain bearish and without a position.
Happy to change my mind if the facts or my view change.
I don’t short stocks, but if I were to take a mid-term short position, my candidate would be $HGRAF
@ 11.18 CAD share price
~4 B$ market cap
The stock is also up +30x over the past year, helped by heavy promotion across social media.
HydroGraph develops graphene, an advanced carbon material often called a “super-material” because it is:
- stronger than steel
- more conductive than copper
- extremely light and flexible
Graphene can be used as an additive to improve many products:
- coatings and lubricants
- batteries and energy storage
- plastics and composites
HydroGraph’s key claim is that its patented “Hyperion” detonation reactor produces ~99.8% pure graphene using industrial gases instead of mined graphite.
The graphene market could eventually be multi-B$ across multiple industries.
Sounds revolutionary, right?
2025 sales: 43k$.
That makes this essentially a pre-revenue narrative/story, while commercial contracts have not materialized at scale. The usual risks around financing and dilution are also present.
Graphene has been hyped for over a decade, yet widespread adoption remains limited:
- manufacturing at industrial scale
- integrating graphene into existing supply chains
- cost vs. alternative materials
Some short reports also argue that the company spends heavily on investment promotion relative to R&D and still lacks meaningful customers.
Short reports can be biased. But they highlight an important point:
The gap between narrative and revenue (and ultimately profitable operations) is very large.
Happy to be proven wrong and hear the arguments from the longs.
But in my view, investors should always do proper due diligence before investing, esp. in these kind of investment cases.
Is this a breakthrough material or just another market narrative?
1
9
1,387




































